Swedish Company Recruits Crows to Catch Cigarette Butts

A carrion crow in flight. Arterra/Universal Images Group, via
Getty Images
A carrion crow in flight. Arterra/Universal Images Group, via Getty Images
TT

Swedish Company Recruits Crows to Catch Cigarette Butts

A carrion crow in flight. Arterra/Universal Images Group, via
Getty Images
A carrion crow in flight. Arterra/Universal Images Group, via Getty Images

Crows are being recruited to pick up discarded cigarette butts from the streets and squares of a Swedish city as part of a cost-cutting drive, The Guardian reported.

The wild birds carry out the task as they receive a little food for every butt that they deposit in a bespoke machine designed by a startup in Södertälje, near Stockholm.

“They are wild birds taking part on a voluntary basis,” said Christian Günther-Hanssen, the founder of Corvid Cleaning, the company behind the method. The Keep Sweden Tidy Foundation says that more than 1bn cigarette butts are left on Sweden’s streets each year, representing 62 percent of all litter.

Södertälje spends 20m Swedish kronor (£1.6m) on street cleaning. Günther-Hanssen estimates his method could save at least 75 percent of costs involved with picking up cigarette butts in the city.

Södertälje is carrying out a pilot project before potentially rolling out the operation across the city. Clever crows use tools in same way as great apes and humans. New Caledonian crows, a member of the corvid family of birds, are as good at reasoning as a human seven-year-old, research has suggested, making them the smartest birds for the job.

“They are easier to teach and there is also a higher chance of them learning from each other. At the same time, there’s a lower risk of them mistakenly eating any rubbish,” Günther-Hanssen said.

The estimation for the cost of picking up cigarette butts today is around 80 öre (Swedish change) or more per cigarette butt, some say two kronor.

Tomas Thernström, a waste strategist at Södertälje municipality, said the potential of the pilot depended on financing.

“It would be interesting to see if this could work in other environments as well. Also, from the perspective that we can teach crows to pick up cigarette butts but we can’t teach people not to throw them on the ground. That’s an interesting thought,” he said.



AstraZeneca: China's Investigation into Exec Separate from Medical Insurance Probe

The AstraZeneca logo is pictured outside the AstraZeneca office building in Brussels, Belgium, January 28, 2021. REUTERS/Johanna Geron/File Photo
The AstraZeneca logo is pictured outside the AstraZeneca office building in Brussels, Belgium, January 28, 2021. REUTERS/Johanna Geron/File Photo
TT

AstraZeneca: China's Investigation into Exec Separate from Medical Insurance Probe

The AstraZeneca logo is pictured outside the AstraZeneca office building in Brussels, Belgium, January 28, 2021. REUTERS/Johanna Geron/File Photo
The AstraZeneca logo is pictured outside the AstraZeneca office building in Brussels, Belgium, January 28, 2021. REUTERS/Johanna Geron/File Photo

AstraZeneca said on Wednesday that to its knowledge an ongoing investigation by Chinese authorities into the company's top executive in the country, Leon Wang, is separate from a large health insurance fraud case also involving the company.

The drugmaker said its Chief Financial Officer Aradhana Sarin had briefed investors on the subject on Wednesday to quell concerns about the fraud probe expanding following a report by financial media company Yicai a day earlier that led its shares to plunge more than 8%.

The Anglo-Swedish drugmaker confirmed on Wednesday that Wang, its China president, was in Chinese custody. One week ago, AstraZeneca said that Wang was under investigation and that the drugmaker would cooperate with authorities, according to Reuters.

AstraZeneca said on Wednesday it did not know what Wang was detained for.

The Yicai report on Tuesday said that dozens of the drugmaker's senior executives in China could be implicated in the largest insurance fraud case in the country's pharma sector in years. But AstraZeneca said on Wednesday that to its knowledge the insurance fraud case did not involve any current AstraZeneca executives.

AstraZeneca has invested heavily in the world's No. 2 pharmaceuticals market.